Allstate Corp lifted its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 100.6% during the 4th quarter, HoldingsChannel reports. The firm owned 9,073 shares of the insurance provider’s stock after purchasing an additional 4,549 shares during the quarter. Allstate Corp’s holdings in Humana were worth $2,324,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Humana by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after purchasing an additional 106,030 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its position in shares of Humana by 28.9% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after acquiring an additional 1,008,514 shares during the last quarter. Pzena Investment Management LLC boosted its position in shares of Humana by 1.0% during the 4th quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider’s stock valued at $1,043,015,000 after acquiring an additional 41,125 shares during the last quarter. Capital International Investors acquired a new position in shares of Humana during the 3rd quarter valued at about $707,670,000. Finally, Invesco Ltd. boosted its position in shares of Humana by 1.3% during the 3rd quarter. Invesco Ltd. now owns 2,043,460 shares of the insurance provider’s stock valued at $531,647,000 after acquiring an additional 25,938 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
HUM has been the topic of several recent research reports. Wells Fargo & Company cut shares of Humana from a “cautious” rating to a “reduce” rating in a research report on Wednesday, May 20th. Needham & Company LLC initiated coverage on shares of Humana in a research report on Wednesday, May 20th. They set a “buy” rating on the stock. Truist Financial boosted their price target on shares of Humana from $220.00 to $270.00 and gave the company a “hold” rating in a research report on Thursday, April 30th. Oppenheimer upgraded Humana from an “outperform” rating to an “outperform” rating in a report on Wednesday, May 20th. Finally, UBS Group upped their price objective on Humana from $262.00 to $320.00 and gave the company a “neutral” rating in a report on Friday, May 22nd. Nine research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $270.48.
Humana Stock Up 0.7%
Shares of HUM opened at $308.41 on Friday. The stock has a market capitalization of $37.03 billion, a PE ratio of 32.99, a P/E/G ratio of 2.22 and a beta of 0.68. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $315.66. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The company’s 50-day simple moving average is $229.25 and its 200-day simple moving average is $228.50.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s quarterly revenue was up 23.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts forecast that Humana Inc. will post 9.01 earnings per share for the current fiscal year.
Humana Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is presently 37.86%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Recommended Stories
- Five stocks we like better than Humana
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
